Vitamin D receptor expression is linked to cell cycle control in normal human keratinocytes

Biochemical and Biophysical Research Communications

Volumn 279, Issue 1, 2000, Pages 89-94

  Segaert, Siegfried ^a   Degreef, Hugo ^a   Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Cell cycle; Growth factors; Keratinocytes; Mimosine; Nocodazole; Starvation; Vitamin D receptor

Indexed keywords

CALCITRIOL; GROWTH FACTOR; MIMOSINE; NOCODAZOLE; VITAMIN D RECEPTOR;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE CONTROL; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL;

EID: 0034627169     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.3892     Document Type: Article

References (42)

1. Structure-function relationships in the vitamin D endocrine system
2. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets
3. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia, and growth retardation after weaning
4. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets and esteomalacia, but not alopecia in vitamin D receptor-ablated mice
5. Vitamin D, calcium, and epidermal differentiation
6. 3 in cultured human epidermal keratinocytes
7. 3 analogues in the treatment of psoriasis
8. Regulation of vitamin D receptor abundance
9. Anchorage-dependent expression of the vitamin D receptor in normal human keratinocytes
10. Suppression of vitamin D receptor and upregulation of retinoid X receptor a expression during squamous differentiation of cultured keratinocytes
11. Ultraviolet B suppresses vitamin D receptor gene expression in keratinocytes
12. The flavonoid apigenin suppresses vitamin D receptor expression and vitamin D responsiveness in normal human keratinocytes
13. Human D-type cyclin
14. WAF1, a potential mediator of p53 tumor suppression
15. 3: Interaction with distinct receptor domains
16. 3: Dependence on cell culture conditions
17. Cancer cell cycles
18. Cell synchronization
19. Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation
20. p21(WAF1/CIP1/SDI1) is elevated through a p53-independent pathway by mimosine
21. 3 receptor gene expression in cultured cells by serum and growth factors
22. The anti-proliferative effect of calcitriol on human peripheral blood mononuclear cells
23. 3
24. 3 receptors in normal and psoriatic skin
25. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid
26. 3 analog KH1060
27. Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice
28. 3
29. 3 in the human prostatic carcinoma cell line ALVA-31
30. 3 in normal human keratinocytes
31. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study
32. 3 are potentiated by epidermal growth factor and attenuated by insulin in cultured human keratinocytes
33. Structural organization of the human vitamin D receptor chromosomal gene and its promoter
34. Cloning and characterization of the mouse vitamin D receptor promoter
35. Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter
36. Interaction between Sp1 and cell cycle regulatory proteins is important in transactivation of a differentiation-related gene
37. Growth/cell cycle regulation of Sp1 phosphorylation
38. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator
39. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB
40. NF-κB inhibits expression of the alpha1(I) collagen gene
41. Inhibition of the RelA(p65) NF-κB subunit by Egr-1
42. Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter